Story perspectives

Global Radioimmunoassay Market Set for $1.12 Billion Surge

9/11/2025

28 2

Summary

Story summary

The global Radioimmunoassay (RIA) market is expected to grow from $710 million in 2024 to $1.12 billion by 2033, with a CAGR of 5.21%.
Increased research in endocrinology, oncology, and infectious diseases drives this growth.
RIA's high sensitivity and specificity maintain its relevance against non-radioactive methods like ELISA.
It plays a key role in diagnosing low doses of drugs, hormones, and antigens, especially in thyroid conditions.
Rising demand in developing countries stems from greater investment in life sciences and personalized medicine.

1 of 1

Story summary

The global Radioimmunoassay (RIA) market is expected to grow from $710 million in 2024 to $1.12 billion by 2033, with a CAGR of 5.21%.
Increased research in endocrinology, oncology, and infectious diseases drives this growth.
RIA's high sensitivity and specificity maintain its relevance against non-radioactive methods like ELISA.
It plays a key role in diagnosing low doses of drugs, hormones, and antigens, especially in thyroid conditions.
Rising demand in developing countries stems from greater investment in life sciences and personalized medicine.